Who Are We?
PARC is a University of Adelaide based research group conducting specialised research into multiple disciplines, lead by Professor Guy Ludbrook.
Professor Guy Ludbrook
The purpose of the Unit is not only to undertake contract clinical research for the pharmaceutical and biotech industries, but also to provide a safe and suitable environment for the conduct of academic clinical studies. PARC has extensive experience in the conduct of clinical research with compounds of narrow therapeutic index - such as opioids and products in early phase of development that require specialised management.
Students conducting higher degree research studies at PARC gain experience in all aspects of clinical trial development and management, and are supported through this process by our highly trained clinical research staff.
PARC is managed by a team of highly trained and experienced staff, with a broad range of expertise, experience and qualifications, including medical personnel, registered nurses, science/bio-science graduates and PhD candidates and recipients. PARC has a dedicated approach to ongoing education for unit staff and facilitates clinical research education access for other users in the health sector, outside of the University.
PARC has a large amount of experience in the conduct of studies in a broad range of therapeutic areas and across various development stages. Our physical location in the RAH and our University heritage allow us access to a large number of specialist clinicians, many who require a unique and flexible facility such as PARC to conduct their clinical research studies - or who can provide patient referrals.
Our highly specialised clinical facility allows for intensive monitoring for narrow therapeutic margin (higher risk) therapies and our non hospital allocated beds allow for overnight and participant studies to be conducted with ease, providing greater flexibility to sponsors and clinicians. PARC operates a 24hour/7 day week testing facility.
Our highly trained and skilled staff has expertise in trial conduct across most formulations, with special expertise in the dosing and handling of schedule 8 and intravenous and infusion therapies. We have considerable experience in the administration and monitoring of participants involved in first in man and early phase studies.
Please visit our page listing the Disease Indications studied in previous clinical trials that have been run at PARC Clinical Research.
To discuss potential collaborations please contact PARC on +61870741544 or go to our Participate page.
Sponsors from Previous Studies Conducted at PARC
Investigators from Previous Study Conducted at PARC
- PROFESSOR DAVID TORPY
- PROFESSOR GUY LUDBROOK
- PROFESSOR BRIAN FREEMAN
- DR. RICHARD WALSH
- DR. TOM PAINTER
- PROFESSOR LOUISE HULL
- PROFESSOR PAUL ROLAN
- PROFESSOR MICHAEL BROWN
- PROFESSOR RUTH MARSHALL
- DR. HECKER
- DR. WHITE
- PROFESSOR G. WITTERT
- DR. JOHN MADDISON
- PROFESSOR STEPHEN WORTHLEY
- DR. DRAGO BRATKOVIC
- PROFESSOR MARK HUTCHINSON
- DR. DAVID KETTERIDGE